Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16060801 | BAY1217389 | 1554458-53-5 | 98% by HPLC |  |
| BAY1217389 is an orally bioavailable, selective inhibitor of the serine/threonine kin | ||||
| 633001 | 6-bromo-2,3,4,4a(S),5,9b(R)-hexahydropyrido[4,3-b]indole | 1059630-07-7 | 98% by HPLC;EE>98% By chiral HPLC | 59b(R)-hexahydropyrido[43-b]indole-cas-1059630-07-7.png) |
| 6-bromo-2,3,4,4a(S),5,9b(R)-hexahydropyrido[4,3-b]indole;CAS#1059630-07-7 provide cus | ||||
| 032512 | BMS-833923 | 1059734-66-5 | 98% |  |
| Coming soon! | ||||
| 032510 | 1-benzyl-4-bromobenzene | 2116-36-1 | 98% |  |
| Coming soon! | ||||
| 032507 | 3-Bromo-2-iodopyridine | 408502-43-2 | 98% |  |
| Coming soon! | ||||
| 032504 | 2,4-bis(benzyloxy)-5-isopropylbenzaldehyde | 959466-51-4 | 98% | -5-isopropylbenzaldehyde-cas-959466-51-4.png) |
| Coming soon! | ||||
| 032502 | 1-bromophenanthrene | 51958-51-1 | 98% |  |
| Coming soon! | ||||
| 031004 | Bibs-39 | 133085-33-3 | 98% |  |
| Coming soon! | ||||
| 030301 | BET bromodomain inhibitor | 1505453-59-7 | 98% |  |
| Coming soon! | ||||
| 020301 | Butacarb | 2655-19-8 | 98% |  |
| Coming soon! | ||||
| 012003 | Burixafor | 1191448-17-5 | 98% |  |
| Burixafor is an orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) wit | ||||
| 011920 | BAY 87-2243 | 1227158-85-1 | 98% |  |
| BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-induced gene activa | ||||
| 011914 | BMS-433796 | 935525-13-6 | 98% |  |
| BMS-433796 is a gamma-secretase inhibitor. | ||||
| 011315 | Bucillamine | 65002-17-7 | 98% |  |
| Bucillamine is an antirheumatic agent developed from tiopronin. | ||||
| 011314 | BLZ945 | 953769-46-5 | 98% |  |
| BLZ945 is a highly selective and brain-penetrant inhibitor of CSF1R with IC50 of 1 nM | ||||
| 011116 | Bindarit | 130641-38-2 | 98% |  |
| Bindarit, a CCL2, CCL7 and CCL8 inhibitor, is an anti-inflammatory agent. | ||||
| 011102 | BMS-690514 | 859853-30-8 | 98% |  |
| BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (E | ||||
| 010818 | BMS-536924 | 468740-43-4 | 98% |  |
| BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM. | ||||
| 010817 | BMS-911543 | 1271022-90-2 | 98% |  |
| BMS-911543 is a potent and selective small-molecule inhibitor of JAK2; displayes pote | ||||
| 010611 | BMS 5 | 1338247-35-0 | 98% |  |
| This product is for custom synthesis. | ||||
| 123014 | BGT-226 free base | 915020-55-2 | 98% |  |
| BGT226 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplas | ||||
| 122947 | Bafetinib | 859212-16-1 | 98% |  |
| Bafetinib is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 | ||||
| 122946 | BMN 673 | 1207456-01-6 | 98% |  |
| BMN 673 is a novel PARP1/2 inhibitor with IC50 of 0.58 nM(PARP1); does not inhibit PA | ||||
| 122920 | BMS-564929 | 627530-84-1 | 98% |  |
| BMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective an | ||||
| 122918 | Beloranib | 251111-30-5 | 98% |  |
| Beloranib is a fumagillin analogue and inhibitor of methionine aminopeptidase 2 (META | ||||
| 122914 | BI-D1870 | 501437-28-1 | 98% |  |
| BI-D1870 is an ATP-competitive inhibitor of S6 ribosome for RSK1/2/3/4 with IC50 of 3 | ||||
| 122840 | BRAF inhibitor | 918505-61-0 | 98% |  |
| BRAF inhibitor is a potent BRAF inhibitor. | ||||
| 122834 | (-)-Blebbistatin | 856925-71-8 | 98% | -Blebbistatin-cas-856925-71-8.png) |
| (-)-Blebbistatin is a selective inhibitor of myosin II ATPase activity with IC50 of 0 | ||||
| 122826 | BQCA | 338747-41-4 | 98% |  |
| Coming soon! | ||||
| 122805 | Balipodect ( TAK-063 ) | 1238697-26-1 | 98% | _1238697-26-1.png) |
| Balipodect (TAK 063 ) is a novel PDE10A inhibitor. It has shown high inhibitory activ | ||||